Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | THRB | P10828 | 2/20 | 0.43 |
| ▸ | FFAR1 | O14842 | 7/20 | 0.39 |
| ▸ | ACACB | O00763 | 4/20 | 0.38 |
| ▸ | PTGDR2 | Q9Y5Y4 | 1/20 | 0.33 |
| ▸ | PTPN1 | P18031 | 1/20 | 0.32 |
| ▸ | PTPN6 | P29350 | 1/20 | 0.32 |
| ▸ | PTPN11 | Q06124 | 1/20 | 0.32 |
| ▸ | PPARG | P37231 | 1/20 | 0.32 |
| ▸ | PPARA | Q07869 | 1/20 | 0.32 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.31 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.31 |
| ▸ | HTT | P42858 | 1/20 | 0.31 |
| ▸ | APP | P05067 | 1/20 | 0.31 |
| ▸ | HPGD | P15428 | 1/20 | 0.30 |
| ▸ | TSHR | P16473 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17370424 | 0.95 | THRB (0.40) | THRBFFAR1ACACBPTGDR2PTPN1 | |
| SCHEMBL12733803 | 0.87 | THRB (0.50) | THRBFFAR1ACACBPTPN1PTPN6 | |
| SCHEMBL19759397 | 0.82 | THRB (0.42) | THRBFFAR1ACACBPTGDR2ALDH1A1 | |
| SCHEMBL17370430 | 0.82 | THRB (0.36) | THRBFFAR1ACACB | |
| SCHEMBL16491598 | 0.81 | APP (0.47) | THRBFFAR1ACACBAPP | |
| SCHEMBL17370433 | 0.81 | POLB (0.37) | THRBFFAR1ACACBHTT | |
| SCHEMBL12242566 | 0.80 | FFAR1 (0.39) | THRBFFAR1ACACBPTGDR2 | |
| SCHEMBL17370399 | 0.80 | POLB (0.34) | THRBFFAR1ACACBHTT | |
| SCHEMBL12242522 | 0.80 | FFAR1 (0.45) | THRBFFAR1ACACBHTTHPGD | |
| SCHEMBL12242480 | 0.80 | FFAR1 (0.45) | THRBFFAR1ACACBHTTHPGD |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9708534-B2 | Polymerizable compound having triple bond, liquid crystal composition and liquid crystal display device | JNC CORPORATION (JP) | 2017-07-18 | — | — | US | disclosed |
| US-9708534-B2 | Polymerizable compound having triple bond, liquid crystal composition and liquid crystal display device | JNC CORPORATION (JP) | 2017-07-18 | — | — | US | disclosed |
| US-20150376505-A1 | POLYMERIZABLE COMPOUND HAVING TRIPLE BOND, LIQUID CRYSTAL COMPOSITION AND LIQUID CRYSTAL DISPLAY DEVICE | JNC PETROCHEMICAL CORPORATION (JP) | 2015-12-31 | — | — | US | disclosed |
| US-20150376505-A1 | POLYMERIZABLE COMPOUND HAVING TRIPLE BOND, LIQUID CRYSTAL COMPOSITION AND LIQUID CRYSTAL DISPLAY DEVICE | JNC PETROCHEMICAL CORPORATION (JP) | 2015-12-31 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150376505-A1 | POLYMERIZABLE COMPOUND HAVING TRIPLE BOND, LIQUID CRYSTAL COMPOSITION AND LIQUID CRYSTAL DISPLAY DEVICE | CCNT1, CCNA1, CCND1 | THRB 4828/4885FFAR1 1862/4885ACACB 2790/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.